Polycystic Ovary Syndrome and Gender Identity.

Androgens Female Gender Dysphoria Gender Identity Humans Hyperandrogenism Insulin Resistance Male Polycystic Ovary Syndrome
PCOS Polycystic Ovary Syndrome gender dysphoria gender identity gender incongruence

Journal

The Yale journal of biology and medicine
ISSN: 1551-4056
Titre abrégé: Yale J Biol Med
Pays: United States
ID NLM: 0417414

Informations de publication

Date de publication:
09 2020
Historique:
entrez: 2 10 2020
pubmed: 3 10 2020
medline: 21 10 2021
Statut: epublish

Résumé

Polycystic ovary syndrome (PCOS) is a common endocrinopathy affecting 46XX individuals of reproductive age. Cardinal features of PCOS include hyperandrogenism, irregular periods, and insulin resistance. Pathogenesis is unclear but likely involves hypothalamic, pituitary, or ovarian abnormalities leading to increased androgen production. In addition, alternative insulin signaling pathways are activated to preserve ovarian sensitivity to insulin while other "classical" tissues (

Identifiants

PMID: 33005117 PMC: PMC7513432
pubmed: 33005117
pii: yjbm934529
pmc: PMC7513432

Substances chimiques

Androgens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

529-537

Informations de copyright

Copyright ©2020, Yale Journal of Biology and Medicine.

Références

J Pediatr Adolesc Gynecol. 2012 Dec;25(6):390-5
pubmed: 23089573
J Clin Endocrinol Metab. 2000 Jan;85(1):139-46
pubmed: 10634377
Fertil Steril. 2004 Jan;81(1):19-25
pubmed: 14711538
Arch Sex Behav. 2006 Dec;35(6):667-84
pubmed: 16902816
Psychoneuroendocrinology. 1997 Jul;22(5):361-80
pubmed: 9279941
Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:149-154
pubmed: 30690191
Endocr Rev. 1999 Aug;20(4):535-82
pubmed: 10453357
Psychoneuroendocrinology. 2016 Nov;73:196-203
pubmed: 27513883
Soc Sci Med. 2002 Feb;54(3):349-61
pubmed: 11824912
Ann Hum Biol. 2008 Nov-Dec;35(6):584-95
pubmed: 18720090
Mol Cell Endocrinol. 1998 Oct 25;145(1-2):111-21
pubmed: 9922107
Hum Reprod. 2007 Apr;22(4):1011-6
pubmed: 17166864
Endocr Rev. 2003 Jun;24(3):302-12
pubmed: 12788801
Lancet. 2003 May 24;361(9371):1810-2
pubmed: 12781553
Front Endocrinol (Lausanne). 2019 Feb 27;10:116
pubmed: 30873121
Fertil Steril. 2009 Feb;91(2):456-88
pubmed: 18950759
Clin Endocrinol (Oxf). 1994 Oct;41(4):463-71
pubmed: 7955457
Biomed Res Int. 2018 Mar 8;2018:6869705
pubmed: 29707577
Acta Obstet Gynecol Scand. 2012 Jun;91(6):710-4
pubmed: 22443151
Fertil Steril. 2009 Dec;92(6):1960-5
pubmed: 18980763
Arch Sex Behav. 2015 Jul;44(5):1363-75
pubmed: 25239661
J Clin Endocrinol Metab. 1961 Nov;21:1440-7
pubmed: 13892577
Iran Red Crescent Med J. 2014 Feb;16(2):e12423
pubmed: 24719724
Endocrinol Metab Clin North Am. 2006 Mar;35(1):137-55, vii
pubmed: 16310646
Gynecol Endocrinol. 2010 Nov;26(11):791-803
pubmed: 20528570
J Obstet Gynaecol Res. 2016 Jun;42(6):678-83
pubmed: 26890011
Endocr Connect. 2020 Mar 1;:
pubmed: 32229703
J Clin Endocrinol Metab. 2001 Aug;86(8):3761-7
pubmed: 11502808
Endocr Rev. 1991 Feb;12(1):3-13
pubmed: 2026121
Oncotarget. 2017 Jul 12;8(56):96351-96358
pubmed: 29221211
N Engl J Med. 1983 Nov 17;309(20):1206-9
pubmed: 6633568
PPAR Res. 2007;2007:49109
pubmed: 17389770
Curr Opin Endocrinol Diabetes Obes. 2012 Dec;19(6):505-11
pubmed: 23108198
Cochrane Database Syst Rev. 2018 May 24;5:CD010287
pubmed: 29797697
Arch Sex Behav. 1986 Feb;15(1):69-78
pubmed: 3964071
J Clin Endocrinol Metab. 2008 Apr;93(4):1408-11
pubmed: 18211977
Endokrynol Pol. 2014;65(3):189-94
pubmed: 24971919
N Engl J Med. 1979 May 31;300(22):1233-7
pubmed: 431680
N Engl J Med. 2007 Feb 8;356(6):551-66
pubmed: 17287476
J Clin Endocrinol Metab. 2003 Mar;88(3):1102-6
pubmed: 12629091
J Obstet Gynaecol Can. 2008 Aug;30(8):671-679
pubmed: 18786289
Johns Hopkins Med J. 1968 Sep;123(3):115-22
pubmed: 5672928
Johns Hopkins Med J. 1968 Mar;122(3):160-7
pubmed: 5645253
Metabolism. 1992 Aug;41(8):903-10
pubmed: 1640871
J Clin Invest. 1995 Aug;96(2):801-10
pubmed: 7635975
J Clin Endocrinol Metab. 2005 Nov;90(11):6099-105
pubmed: 16131582
Clin Endocrinol (Oxf). 1993 Mar;38(3):325-9
pubmed: 8458105
Am J Med. 1995 Jan 16;98(1A):33S-39S
pubmed: 7825639
Ann Agric Environ Med. 2017 Sep 21;24(3):522-526
pubmed: 28954502
Birth Defects Orig Artic Ser. 1975;11(4):91-103
pubmed: 1156691
J Clin Endocrinol Metab. 1988 Sep;67(3):460-4
pubmed: 2842359
N Engl J Med. 2014 Jul 10;371(2):119-29
pubmed: 25006718
South Med J. 1987 Apr;80(4):483-6
pubmed: 3563583

Auteurs

Minghao Liu (M)

Division of Endocrinology, Friedman Transgender Health and Wellness Program, Department of Medicine, Lenox Hill Hospital, Northwell Health, New York, NY.
Donald and Barbara Zucker School of Medicine at Hofstra University, Hempstead, NY.

Swetha Murthi (S)

Division of Endocrinology, Friedman Transgender Health and Wellness Program, Department of Medicine, Lenox Hill Hospital, Northwell Health, New York, NY.
Donald and Barbara Zucker School of Medicine at Hofstra University, Hempstead, NY.

Leonid Poretsky (L)

Division of Endocrinology, Friedman Transgender Health and Wellness Program, Department of Medicine, Lenox Hill Hospital, Northwell Health, New York, NY.
Donald and Barbara Zucker School of Medicine at Hofstra University, Hempstead, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Hormones, substituts d'hormones et antagonistes d'hormones › Hormones › Androgènes › Polycystic Ovary Syndrome and Gender Identity.
questionsmedicales.fr › Troubles mentaux › Dysfonctionnements sexuels psychogènes › Dysphorie de genre › Polycystic Ovary Syndrome and Gender Identity.
questionsmedicales.fr › Phénomènes psychologiques › Théorie psychologique › Théorie psychanalytique › Développement psychosexuel › Identité de genre › Polycystic Ovary Syndrome and Gender Identity.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Polycystic Ovary Syndrome and Gender Identity.
questionsmedicales.fr › Maladies endocriniennes › Troubles gonadiques › Troubles du développement sexuel › Syndrome génitosurrénal › Hyperandrogénie › Polycystic Ovary Syndrome and Gender Identity.
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Insulinorésistance › Polycystic Ovary Syndrome and Gender Identity.
questionsmedicales.fr › Maladies endocriniennes › Troubles gonadiques › Maladies ovariennes › Kystes de l'ovaire › Syndrome des ovaires polykystiques › Polycystic Ovary Syndrome and Gender Identity.